Nasdaq: ABCL
AbCellera Biologics insiders
The officers, directors and 10% owners of AbCellera Biologics Inc. who hold the most stock, valued at the live ABCL price.
$10.47
ABCL today −$550K (−4.99%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their ABCL stock
- $728M
- Market value
- $3.42B
- Held by ranked insiders
- 21.3%
Insiders by value of ABCL holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Thermopylae Holdings Ltd. | 10% owner | 56,069,662 | $587M | 17.2% | Corporate |
| 2 | Veronique Lecault | Chief Operating Officer | 9,613,674 | $101M | 2.94% | 1492nd |
| 3 | Michael R. Hayden | Director | 1,491,642 | $15.6M | 0.46% | 5519th |
| 4 | Carl L. G. Hansen | Chief Executive Officer | 898,000 | $9.4M | 0.27% | 9202nd |
| 5 | Stephen Quake | Director | 836,136 | $8.8M | 0.26% | 9700th |
| 6 | Andrew Booth | Chief Financial Officer | 622,359 | $6.5M | 0.19% | 12014th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for AbCellera Biologics; see each profile for the filing.